Show simple item record

2021-06-19Zeitschriftenartikel DOI: 10.1016/j.lanepe.2021.100103
Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020
dc.contributor.authorUlrich, Alexander
dc.contributor.authorSchranz, Madlen
dc.contributor.authorRexroth, Ute
dc.contributor.authorHamouda, Osamah
dc.contributor.authorSchaade, Lars
dc.contributor.authorDiercke, Michaela
dc.contributor.authorBoender, Sonia T.
dc.date.accessioned2021-07-05T07:21:33Z
dc.date.available2021-07-05T07:21:33Z
dc.date.issued2021-06-19none
dc.identifier.urihttp://edoc.rki.de/176904/8478
dc.description.abstractBackground The COVID-19 pandemic and associated non-pharmaceutical interventions (NPIs) affect healthcare seeking behaviour, access to healthcare, test strategies, disease notification and workload at public health authorities, but may also lead to a true change in transmission dynamics. We aimed to assess the impact of the pandemic and NPIs on other notifiable infectious diseases under surveillance in Germany. Methods We included 32 nationally notifiable disease categories with case numbers >100/year in 2016–2019. We used quasi-Poisson regression analysis on a weekly aggregated time-series incorporating trend and seasonality, to compute the relative change in case numbers during week 2020–10 to 2020–32 (pandemic/NPIs), in comparison to week 2016–01 to 2020–09. Findings During week 2020–10 to 2020–32, 216,825 COVID-19 cases, and 162,942 (-35%) cases of other diseases, were notified. Case numbers decreased across all ages and notification categories (all p<0•05), except for tick-borne encephalitis, which increased (+58%). The number of cases decreased most for respiratory diseases (from -86% for measles, to -12% for tuberculosis), gastro-intestinal diseases (from -83% for rotavirus gastroenteritis, to -7% for yersiniosis) and imported vector-borne diseases (-75% dengue fever, -73% malaria). The less affected infections were healthcare associated pathogens (from -43% infection/colonisation with carbapenem-non-susceptible Acinetobacter, to -28% for Methicillin-resistant Staphylococcus aureus invasive infection) and sexually transmitted and blood-borne diseases (from -28% for hepatitis B, to -12% for syphilis). Interpretation During the COVID-19 pandemic a drastic decrease of notifications for most infectious diseases and pathogens was observed. Our findings suggest effects of NPIs on overall disease transmission that require further investigation.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectPublic health surveillanceeng
dc.subjectCOVID-19eng
dc.subjectPandemicseng
dc.subjectDisease transmission, infectiouseng
dc.subjectCohort studieseng
dc.subjectGeneral Practitionerseng
dc.subjectEpidemiologyeng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleImpact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020none
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/8478-7
dc.identifier.doi10.1016/j.lanepe.2021.100103
dc.identifier.doihttp://dx.doi.org/10.25646/8749
dc.type.versionpublishedVersionnone
local.edoc.container-titleThe Lancet Regional Health - Europenone
local.edoc.container-issn2666-7762none
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.sciencedirect.com/science/article/pii/S2666776221000806?via%3Dihubnone
local.edoc.container-publisher-nameElseviernone
local.edoc.container-volume7none
local.edoc.rki-departmentInfektionsepidemiologienone
dc.description.versionPeer Reviewednone

Show simple item record